DE68908117D1 - N-acetylglukosamin als zytoprotektives mittel. - Google Patents

N-acetylglukosamin als zytoprotektives mittel.

Info

Publication number
DE68908117D1
DE68908117D1 DE8989311710T DE68908117T DE68908117D1 DE 68908117 D1 DE68908117 D1 DE 68908117D1 DE 8989311710 T DE8989311710 T DE 8989311710T DE 68908117 T DE68908117 T DE 68908117T DE 68908117 D1 DE68908117 D1 DE 68908117D1
Authority
DE
Germany
Prior art keywords
acetyl glucosamine
cytoprotective agent
cytoprotective
agent
glucosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989311710T
Other languages
English (en)
Other versions
DE68908117T2 (de
Inventor
Albert F Burton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of DE68908117D1 publication Critical patent/DE68908117D1/de
Application granted granted Critical
Publication of DE68908117T2 publication Critical patent/DE68908117T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
DE89311710T 1988-11-18 1989-11-13 N-Acetylglukosamin als zytoprotektives Mittel. Expired - Fee Related DE68908117T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000583439A CA1318592C (en) 1988-11-18 1988-11-18 N-acetyl glucosamine as a cytoprotective agent

Publications (2)

Publication Number Publication Date
DE68908117D1 true DE68908117D1 (de) 1993-09-09
DE68908117T2 DE68908117T2 (de) 1993-12-02

Family

ID=4139122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89311710T Expired - Fee Related DE68908117T2 (de) 1988-11-18 1989-11-13 N-Acetylglukosamin als zytoprotektives Mittel.

Country Status (8)

Country Link
EP (1) EP0372730B1 (de)
JP (1) JPH0678235B2 (de)
KR (1) KR0145715B1 (de)
AT (1) ATE92313T1 (de)
AU (1) AU623197B2 (de)
CA (1) CA1318592C (de)
DE (1) DE68908117T2 (de)
ES (1) ES2058552T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
AU3881493A (en) * 1992-03-19 1993-10-21 University Of British Columbia, The Method and composition for suppression of side effects of anti-inflammatory drugs
WO1993023055A1 (en) * 1992-05-15 1993-11-25 The University Of British Columbia N-acetyl glucosamine as gastroprotective agent
GB9315846D0 (en) * 1993-07-30 1993-09-15 Isis Innovation Tumour inhibitors
CA2408023C (en) * 2002-10-15 2012-01-03 Purepharm Inc. Glucosamine as a food and beverage additive
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
CN1232257C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备治疗和控制物理化学因素致非特异性炎症的药物中的应用
CN1210038C (zh) 2003-03-27 2005-07-13 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用
CN1533776A (zh) * 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
US20070197470A1 (en) * 2003-09-17 2007-08-23 Qiwang Xu Use of n-acetyl-d-aminogylcosamine in preparation of drugs for modulating microorganisms on mucous membrane
JP2007506645A (ja) * 2003-09-17 2007-03-22 中国人民解放▲軍▼第三▲軍▼医大学 抗腫瘍および抗転移のための製剤の製造におけるn−アセチル−d−グルコサミンの使用
EP1669077A4 (de) * 2003-09-18 2007-10-03 Univ Pla 3Rd Military Medical Antibakterielle zusammensetzungen von n-acetyl-d-aminoglycosamin und antibiotika
US20100105634A1 (en) * 2007-03-07 2010-04-29 Cargill, Incorporated Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
EP3737384B1 (de) * 2018-03-08 2023-10-25 Purepharm Inc. Verfahren und zusammensetzungen zur vorbeugung und behandlung von störungen im zusammenhang mit alpha-synuclein
KR102629903B1 (ko) * 2019-12-18 2024-02-16 주식회사 글로원 N-아세틸글루코사민 유도체를 유효성분으로 함유하는 주입용 필러 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792346C3 (de) * 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
US4006224A (en) * 1975-09-29 1977-02-01 Lescarden Ltd. Method and agent for treating inflammatory disorders of the gastrointestinal tract
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
GB8524807D0 (en) * 1985-10-08 1985-11-13 Hendry N G C Tissue growth regulation
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen

Also Published As

Publication number Publication date
CA1318592C (en) 1993-06-01
AU4536289A (en) 1990-05-24
KR900007424A (ko) 1990-06-01
ATE92313T1 (de) 1993-08-15
AU623197B2 (en) 1992-05-07
JPH02237929A (ja) 1990-09-20
EP0372730B1 (de) 1993-08-04
JPH0678235B2 (ja) 1994-10-05
ES2058552T3 (es) 1994-11-01
KR0145715B1 (ko) 1998-08-17
DE68908117T2 (de) 1993-12-02
EP0372730A3 (en) 1990-06-20
EP0372730A2 (de) 1990-06-13

Similar Documents

Publication Publication Date Title
DE68908117D1 (de) N-acetylglukosamin als zytoprotektives mittel.
DE68909693D1 (de) Angetriebenes Atemgerät.
NL190832C (nl) Tandbehandelingsmiddel met anti-tandsteenwerking.
DE68903516D1 (de) Mittel zur senkung des blutdrucks.
AU8318187A (en) Hair care composition modified aminoalkyl substituted polydiorganosiloxane
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE3667728D1 (de) Schutzvorrichtung fuer den menschlichen koerper.
DE68904151D1 (de) Rollstuhlvorrichtung.
DE68927474D1 (de) Neuro-Rechner
DK90089A (da) Hudbehandlingspraeparat
DE68910799D1 (de) Faserbehandlungszusammensetzung.
DE3876288D1 (de) Desinfektions- und sterilisierungsmittel.
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
KR900007411A (ko) Nb-818의 용이흡수성 약제
ATE12159T1 (de) Desinfektions- und steril isierungszusammensetzung.
FR2629557B1 (fr) Clapet de non retour asservissable
DE58906881D1 (de) Gerät zur Zahnbehandlung.
DE3878774D1 (de) Paraherquamid und dihydroparaherquamid als antiparasitaere mittel.
DE68913088D1 (de) Faserbehandlungszusammensetzung.
DE68910100D1 (de) Mittel zur Bluttrennung.
DE3853841D1 (de) Nichtfleckenbildende und wenigfleckenbildende Ozon-Schutzmittel.
ATE42462T1 (de) Licht- und sonnenschutzmittel.
NO164820C (no) Redningstrapp.
DE68913090D1 (de) Modifizierter menschlicher PSTI.
DE68922188D1 (de) Rettungs- und Rückspeicherungsverfahren und Prozessorsystem dafür.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee